Reality check: Real-world evidence to support therapeutic development in hematologic malignancies

March 3, 2022

In this Blood Reviews article, COTA researchers, along with academic collaborators from UT Southwestern, Med. College of Wisconsin, U. Chicago, Sarah Cannon Blood Cancer Network and Case Western Reserve University, review promising use cases for RWD, particularly for hematologic malignancies. Read the article in the March issue of Blood Reviews

Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry
  • This field is for validation purposes and should be left unchanged.